We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Will Cataract Surgery Eliminate Glasses?

By HospiMedica staff writers
Posted on 09 Oct 2006
Improvements in the lenses implanted in the eye during cataract surgery have led to a new surgical option for treating people with farsightedness and other refractive-lens exchange surgery. More...


Multifocal intraocular lenses (MIOL)--which have been implanted since 1986--enable people to see objects at varying distances by shifting their eyes slightly. MIOLs are currently approved by the U.S. Food and Drug Administration (FDA) only for patients undergoing cataract surgery. Some ophthalmologists are also implanting them into the eyes of people without cataracts in order to correct presbyopia, a common form of farsightedness that typically develops in middle age. However, in many cases the surgery will not result in clear 20/20 vision, and other problems, such as reduced contrast perception and increased glare, may be complications of the surgery.

The surgery requires removing the eyes' natural lenses, as is done in cataract surgery, and replacing them with artificial lenses. However, while many ophthalmologists are reluctant to perform this procedure in people without cataracts because of the risks involved in any eye operation, many people are considering this option, despite lack of information about long-term safety and effectiveness. Risks of the operation already known include a very small chance of infection that may lead to blindness.

Both the surgical procedure and its dangers are discussed in a new report called "The Aging Eye: Preventing and Treating Eye Disease” that reviews all the options for treating presbyopia and other common conditions affecting people as they grow older, released by clinical instructors in ophthalmology at Harvard Medical School (Cambridge, MA, USA). Other conditions discussed are new medications for macular degeneration, treatments for glaucoma, prevention of diabetic retinopathy, and ways of dealing with watery eyes, dry eyes, and other age-related problems.



Related Links:
Harvard Medical School

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.